<DOC>
	<DOCNO>NCT01428310</DOCNO>
	<brief_summary>This study consist 2 phase . Phase 1 one day crossover study see effect study product smoker 's desire smoke , measure change score questionnaire give time . Phase 2 two-week extension , subject self-administer study product visit study site assessment desire smoke collection sample evaluation smoking-related biomarkers .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy Dietary Supplement Anatabloc Reducing Daily Smokers ' Urge Smoke</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<criteria>healthy adult smoker use least 1 pack cigarette per day , least 5 year allergy study product component</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>dietary supplement</keyword>
	<keyword>nutraceutical</keyword>
</DOC>